BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7481393)

  • 1. [Pure cerebellar syndrome associated with anti-Hu antibodies].
    Pradat PF; Uchuya M; Fontaine B; Lubetzki C
    Rev Neurol (Paris); 1995 May; 151(5):341-3. PubMed ID: 7481393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic cerebellar degeneration].
    Chabriat H; Chen QM; Poisson M; Delattre JY
    Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K; Tanaka M; Onodera O; Tsuji S
    Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmunity and paraneoplastic neurologic syndromes].
    Delattre JY; Davila L; Vega F; Poisson M
    Rev Neurol (Paris); 1991; 147(8-9):549-56. PubMed ID: 1962063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive dysautonomia as initial manifestation of anti-Hu antibody-related syndrome].
    Palao S; Corral I; Vera R; Alonso de Leciñana M
    Neurologia; 2007 Dec; 22(10):899-902. PubMed ID: 18040905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M; Vitaliani R; Pezzani R; Nicolao P; Betterle C; Keir G; Thompson EJ; Tavolato B; Scaravilli F; Giometto B
    J Neurol Sci; 2004 May; 220(1-2):29-36. PubMed ID: 15140602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
    Anderson NE; Rosenblum MK; Posner JB
    Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
    Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurologic paraneoplastic syndromes and anti-neuronal antibodies].
    Mygland A
    Tidsskr Nor Laegeforen; 1996 Jan; 116(3):361-5. PubMed ID: 8638263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of paraneoplastic neurological syndromes].
    Kovács GG; Voigtländer T
    Orv Hetil; 2004 Oct; 145(40):2027-33. PubMed ID: 15559529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M; Tanaka K; Idezuka J; Tsuji S
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic syndromes associated with anti-Hu antibodies.
    Senties-Madrid H; Vega-Boada F
    Isr Med Assoc J; 2001 Feb; 3(2):94-103. PubMed ID: 11344832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
    Cohen AB; Zupa-Fernandez A; Dalmau J; Galetta SL
    J Neurol Sci; 2004 Oct; 225(1-2):153-5. PubMed ID: 15465100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraneoplastic cerebellar degeneration as initial presentation of a pancreatic small-cell carcinoma].
    Salmerón-Ato P; Medrano V; Morales-Ortiz A; Martínez-García FA; Villaverde-González R; Bas A; Fernández-Barreiro A; Moltó-Jordà JM
    Rev Neurol; 2002 Dec 16-31; 35(12):1112-5. PubMed ID: 12497294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune paraneoplastic cerebellar degeneration].
    Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
    Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
    Storstein A; Monstad SE; Honnorat J; Vedeler CA
    J Neuroimmunol; 2004 Oct; 155(1-2):150-4. PubMed ID: 15342206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.
    Greenlee JE; Brashear HR; Jaeckle KA; Geleris A; Jordan K
    West J Med; 1992 Feb; 156(2):199-202. PubMed ID: 1536083
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of specific neuronal anti-Hu antibody in the early diagnosis of small cell lung cancer].
    Wang G; Chen Q; Zhu Y; Ke D; Qian W; Song W
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Dec; 25(12):732-5. PubMed ID: 12622892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.